Hyvolt II

Ergon Refining, Inc.

Revision date : 2009-10-01

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

64742-53-6

Name of the chemical

Distillates (petroleum), hydrotreated light naphthenic

Concentration

N/A

EC/CAS

128-37-0

Name of the chemical

2,6-di-tert-butyl-p-cresol

Concentration

N/A

General Information

Revision date

2009-10-01

Product name

Hyvolt II

Product Synonyms

Contains Oil

Chemical name

Severely Hydrotreated Light Naphthenic Distillate

CAS No.

64742-53-6

Manufacturer Name

Ergon Refining, Inc.

Emergency telephone

Ergon Refining, Inc. (601) 638-4960 Normal Business Hours

Icons in SDS

Company Information

company name

Ergon Refining, Inc.

Section 2

SECTION 2: Hazards identification

Emergency Overview ����� HMIS H 1 Not Expected to cause a severe emergency hazard. F 1 R 0

Potential health effects

PPE† B

Principle Routes of Exposure

Skin †Sec. 8 Inhalation: Inhalation of vapors or mist may be irritating to respiratory passages. Prolonged exposure may result in dizziness and nausea. Target Organ for mineral oil mist is lungs. Eye: Eye contact may result in slight irritation and redness. Skin: Short term contact with skin is unlikely to cause any problems; excessive or prolonged and repeated contact and poor hygiene conditions may result in dryness, dermatitis, erythema, oil acne, cracking and defatting of the skin. Ingestion: May result in nausea or stomach discomfort. Carcinogenicity: Based on OSHA 1910.1200 and IARC study requirements, this product does not require labeling. Meets EU requirement of less than 3% (w/w) DMSO extract for total polycyclic aromatic compound (PAC) using IP 346. NTP and OSHA do not list this product as a potential carcinogen. Mutagenicty: This product gives negative mutagenic results from Modified Ames Assay.

Medical Conditions Generally Aggravated by Exposure

Personnel with pre-existing skin disorders should avoid contact with this product. October 1, 2009

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.